Decheng Capital
Latest statistics and disclosures from Decheng Capital's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0002010850
Tip: Access up to 7 years of quarterly data
Positions held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Decheng Capital
Decheng Capital holds 24 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Alpine Immune Sciences (ALPN) | 37.7 | $135M | 7.1M | 19.06 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 8.9 | $32M | 2.1M | 15.15 |
|
|
| Pacific Biosciences of California (PACB) | 8.1 | $29M | 2.9M | 9.81 |
|
|
| 10x Genomics Cl A Com (TXG) | 5.6 | $20M | 360k | 55.96 |
|
|
| ImmunoGen | 5.5 | $20M | 660k | 29.65 |
|
|
| Arcus Biosciences Incorporated (RCUS) | 4.6 | $17M | 870k | 19.10 |
|
|
| Karuna Therapeutics Ord | 4.2 | $15M | 47k | 316.51 |
|
|
| Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) | 4.0 | $14M | 1.3M | 11.23 |
|
|
| Illumina (ILMN) | 3.1 | $11M | 81k | 139.24 |
|
|
| Argenx SE SHS (ARGX) | 2.9 | $10M | 27k | 380.43 |
|
|
| Acelyrin (SLRN) | 2.9 | $10M | 1.4M | 7.46 |
|
|
| Krystal Biotech (KRYS) | 2.3 | $8.2M | 66k | 124.06 |
|
|
| Phathom Pharmaceuticals (PHAT) | 2.2 | $7.8M | 850k | 9.13 |
|
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.6 | $5.7M | 92k | 62.00 |
|
|
| Terns Pharmaceuticals (TERN) | 1.3 | $4.6M | 714k | 6.49 |
|
|
| Aura Biosciences (AURA) | 1.3 | $4.6M | 516k | 8.86 |
|
|
| BeyondSpring SHS (BYSI) | 1.2 | $4.5M | 5.0M | 0.90 |
|
|
| Equillium (EQ) | 0.9 | $3.2M | 4.4M | 0.72 |
|
|
| AtriCure (ATRC) | 0.5 | $1.7M | 46k | 35.69 |
|
|
| Cue Health (HLTH) | 0.4 | $1.5M | 9.0M | 0.16 |
|
|
| Scynexis Com New (SCYX) | 0.3 | $1.2M | 556k | 2.23 |
|
|
| Aadi Bioscience (AADI) | 0.3 | $1.1M | 526k | 2.02 |
|
|
| Pyxis Oncology (PYXS) | 0.2 | $588k | 327k | 1.80 |
|
|
| GeneDx Holdings Corp. Com Cl A (WGS) | 0.1 | $285k | 104k | 2.75 |
|
Past Filings by Decheng Capital
SEC 13F filings are viewable for Decheng Capital going back to 2023
- Decheng Capital 2023 Q4 filed Feb. 12, 2024